Cargando…

Prognostic death factors in secondary hemophagocytic lymphohistiocytosis children with multiple organ dysfunction syndrome receiving continuous renal replacement therapy: A multicenter prospective nested case‐control study

INTRODUCTION: Multiple organ dysfunction syndrome (MODS) with secondary hemophagocytic lymphohistiocytosis (SHLH) causes significant mortality. We aimed to identify the predictor factors for death in pediatric patients with SHLH‐associated MODS receiving continuous renal replacement therapy (CRRT)....

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Yun, Shi, Jingyi, Lu, Guoping, Wang, Ying, Zhu, Xiaodong, Ren, Hong, Zhu, Yueniu, Yan, Gangfeng, Wang, Chunxia, Zhang, Yucai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540864/
https://www.ncbi.nlm.nih.gov/pubmed/34877787
http://dx.doi.org/10.1111/1744-9987.13775
_version_ 1784803798024192000
author Cui, Yun
Shi, Jingyi
Lu, Guoping
Wang, Ying
Zhu, Xiaodong
Ren, Hong
Zhu, Yueniu
Yan, Gangfeng
Wang, Chunxia
Zhang, Yucai
author_facet Cui, Yun
Shi, Jingyi
Lu, Guoping
Wang, Ying
Zhu, Xiaodong
Ren, Hong
Zhu, Yueniu
Yan, Gangfeng
Wang, Chunxia
Zhang, Yucai
author_sort Cui, Yun
collection PubMed
description INTRODUCTION: Multiple organ dysfunction syndrome (MODS) with secondary hemophagocytic lymphohistiocytosis (SHLH) causes significant mortality. We aimed to identify the predictor factors for death in pediatric patients with SHLH‐associated MODS receiving continuous renal replacement therapy (CRRT). METHODS: This multicentered nested case–control study was conducted from 2016 to 2020. The characteristics were compared between survivors and non‐survivors. Logistic regression was applied to identify the risk factors for death. The cutoff values were assessed by receiver operating characteristics curves. RESULTS: Fifty two patients were enrolled in this study. Interleukin‐6 level (p = 0.018) and the number of organ dysfunction (p = 0.047) were independent risk factors for death. The cutoff value of 13.12 pg/ml interleukin‐6 and three organs dysfunction at CRRT initiation presented a high sensitivity and specificity. CONCLUSION: The number of organ dysfunction and interleukin‐6 at CRRT initiation are independent risk factors for death in pediatric patients with SHLH‐associated MODS.
format Online
Article
Text
id pubmed-9540864
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-95408642022-10-14 Prognostic death factors in secondary hemophagocytic lymphohistiocytosis children with multiple organ dysfunction syndrome receiving continuous renal replacement therapy: A multicenter prospective nested case‐control study Cui, Yun Shi, Jingyi Lu, Guoping Wang, Ying Zhu, Xiaodong Ren, Hong Zhu, Yueniu Yan, Gangfeng Wang, Chunxia Zhang, Yucai Ther Apher Dial Original Articles INTRODUCTION: Multiple organ dysfunction syndrome (MODS) with secondary hemophagocytic lymphohistiocytosis (SHLH) causes significant mortality. We aimed to identify the predictor factors for death in pediatric patients with SHLH‐associated MODS receiving continuous renal replacement therapy (CRRT). METHODS: This multicentered nested case–control study was conducted from 2016 to 2020. The characteristics were compared between survivors and non‐survivors. Logistic regression was applied to identify the risk factors for death. The cutoff values were assessed by receiver operating characteristics curves. RESULTS: Fifty two patients were enrolled in this study. Interleukin‐6 level (p = 0.018) and the number of organ dysfunction (p = 0.047) were independent risk factors for death. The cutoff value of 13.12 pg/ml interleukin‐6 and three organs dysfunction at CRRT initiation presented a high sensitivity and specificity. CONCLUSION: The number of organ dysfunction and interleukin‐6 at CRRT initiation are independent risk factors for death in pediatric patients with SHLH‐associated MODS. John Wiley & Sons Australia, Ltd 2021-12-22 2022-10 /pmc/articles/PMC9540864/ /pubmed/34877787 http://dx.doi.org/10.1111/1744-9987.13775 Text en © 2021 The Authors. Therapeutic Apheresis and Dialysis published by John Wiley & Sons Australia, Ltd on behalf of International Society for Apheresis, Japanese Society for Apheresis, and Japanese Society for Dialysis Therapy. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Cui, Yun
Shi, Jingyi
Lu, Guoping
Wang, Ying
Zhu, Xiaodong
Ren, Hong
Zhu, Yueniu
Yan, Gangfeng
Wang, Chunxia
Zhang, Yucai
Prognostic death factors in secondary hemophagocytic lymphohistiocytosis children with multiple organ dysfunction syndrome receiving continuous renal replacement therapy: A multicenter prospective nested case‐control study
title Prognostic death factors in secondary hemophagocytic lymphohistiocytosis children with multiple organ dysfunction syndrome receiving continuous renal replacement therapy: A multicenter prospective nested case‐control study
title_full Prognostic death factors in secondary hemophagocytic lymphohistiocytosis children with multiple organ dysfunction syndrome receiving continuous renal replacement therapy: A multicenter prospective nested case‐control study
title_fullStr Prognostic death factors in secondary hemophagocytic lymphohistiocytosis children with multiple organ dysfunction syndrome receiving continuous renal replacement therapy: A multicenter prospective nested case‐control study
title_full_unstemmed Prognostic death factors in secondary hemophagocytic lymphohistiocytosis children with multiple organ dysfunction syndrome receiving continuous renal replacement therapy: A multicenter prospective nested case‐control study
title_short Prognostic death factors in secondary hemophagocytic lymphohistiocytosis children with multiple organ dysfunction syndrome receiving continuous renal replacement therapy: A multicenter prospective nested case‐control study
title_sort prognostic death factors in secondary hemophagocytic lymphohistiocytosis children with multiple organ dysfunction syndrome receiving continuous renal replacement therapy: a multicenter prospective nested case‐control study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540864/
https://www.ncbi.nlm.nih.gov/pubmed/34877787
http://dx.doi.org/10.1111/1744-9987.13775
work_keys_str_mv AT cuiyun prognosticdeathfactorsinsecondaryhemophagocyticlymphohistiocytosischildrenwithmultipleorgandysfunctionsyndromereceivingcontinuousrenalreplacementtherapyamulticenterprospectivenestedcasecontrolstudy
AT shijingyi prognosticdeathfactorsinsecondaryhemophagocyticlymphohistiocytosischildrenwithmultipleorgandysfunctionsyndromereceivingcontinuousrenalreplacementtherapyamulticenterprospectivenestedcasecontrolstudy
AT luguoping prognosticdeathfactorsinsecondaryhemophagocyticlymphohistiocytosischildrenwithmultipleorgandysfunctionsyndromereceivingcontinuousrenalreplacementtherapyamulticenterprospectivenestedcasecontrolstudy
AT wangying prognosticdeathfactorsinsecondaryhemophagocyticlymphohistiocytosischildrenwithmultipleorgandysfunctionsyndromereceivingcontinuousrenalreplacementtherapyamulticenterprospectivenestedcasecontrolstudy
AT zhuxiaodong prognosticdeathfactorsinsecondaryhemophagocyticlymphohistiocytosischildrenwithmultipleorgandysfunctionsyndromereceivingcontinuousrenalreplacementtherapyamulticenterprospectivenestedcasecontrolstudy
AT renhong prognosticdeathfactorsinsecondaryhemophagocyticlymphohistiocytosischildrenwithmultipleorgandysfunctionsyndromereceivingcontinuousrenalreplacementtherapyamulticenterprospectivenestedcasecontrolstudy
AT zhuyueniu prognosticdeathfactorsinsecondaryhemophagocyticlymphohistiocytosischildrenwithmultipleorgandysfunctionsyndromereceivingcontinuousrenalreplacementtherapyamulticenterprospectivenestedcasecontrolstudy
AT yangangfeng prognosticdeathfactorsinsecondaryhemophagocyticlymphohistiocytosischildrenwithmultipleorgandysfunctionsyndromereceivingcontinuousrenalreplacementtherapyamulticenterprospectivenestedcasecontrolstudy
AT wangchunxia prognosticdeathfactorsinsecondaryhemophagocyticlymphohistiocytosischildrenwithmultipleorgandysfunctionsyndromereceivingcontinuousrenalreplacementtherapyamulticenterprospectivenestedcasecontrolstudy
AT zhangyucai prognosticdeathfactorsinsecondaryhemophagocyticlymphohistiocytosischildrenwithmultipleorgandysfunctionsyndromereceivingcontinuousrenalreplacementtherapyamulticenterprospectivenestedcasecontrolstudy